Grace Therapeutics
Grace Therapeutics is a late-stage biopharma with a target PDUFA date of 2Q'26 for GTx-104. Partnership interests in CNS, immunology and oncology.
Address
PrincetonNJ
United States
NJ
United States
)
January 12-15, 2026 | San Francisco Marriott Marquis, CA
January 12-15, 2026 | San Francisco Marriott Marquis, CA
)
)
NJ
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)